Lemborexant Treatment of Insomnia Linked to Epilepsy (NCT06262594)

🧪 Interventions in This Study

• Lemborexant (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• Duke University — Durham, North Carolina
• Health Sciences Centre — Winnipeg, Manitoba

📞 Contact the Study Coordinator

Phone: (204) 787-2684

Email: letoile@umanitoba.ca

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Epilepsy

• Neural Circulatory Control and SUDEP Risk. — Rochester, Minnesota
• BHV-7000 Responsive Neurostimulation System (RNS) Study — New Haven, Connecticut
• RESEARCH EVALUATING VAGAL EXCITATION AND ANATOMICAL LINKS — Stanford, California
• Acute Recording of Stereotyped High-Frequency Oscillations — Rochester, Minnesota
• Neurophysiologically Based Brain State Tracking and Modulation in Focal Epilepsy — Rochester, Minnesota
• Acoustic Stimulation for Seizure Suppression — New York, New York

Explore by condition: All Epilepsy clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.